Advances in Chronic Kidney Disease
Volume 11, Issue 4 , Pages 377-386 , October 2004

Rationale for growth hormone therapy in children with chronic kidney disease

  • Larry A. Greenbaum

      Affiliations

    • Medical College of Wisconsin and the Children’s Research Institute of the Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, USA
    • Corresponding Author InformationAddress correspondence to Larry A. Greenbaum, MD, PhD, Medical College of Wisconsin, Department of Pediatrics, 8701 Watertown Plank Rd, Milwaukee, WI 53226
    • Dr. Greenbaum and Dr. Kaskel have served as consultants for Genentech, Inc.
    • ,
  • Marcela Del Rio

      Affiliations

    • Children’s Hospital at Montefiore, Section of Nephrology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, USA
    • ,
  • Fatai Bamgbola

      Affiliations

    • Section of Nephrology, Oklahoma University Health Science Center, Oklahoma City, Oklahoma, USA
    • ,
  • Frederick Kaskel

      Affiliations

    • Children’s Hospital at Montefiore, Section of Nephrology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, USA
    • Dr. Greenbaum and Dr. Kaskel have served as consultants for Genentech, Inc.

References 

  1. Hokken-Koelega AC , van Zaal MA , van Bergen W , et al.   Final height and its predictive factors after renal transplantation in childhood . Pediatr Res . 1994;36:323–328
  2. Rizzoni G , Broyer M , Brunner FP , et al.   Combined report on regular dialysis and transplantation of children in Europe, XIII, 1983 . Proc Eur Dial Transplant Assoc . 1985;21:66–95
  3. Ho M , Stablein DM . North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Annual Report. Rockville, Maryland . 2003;
  4. Schaefer F , Wingen AM , Hennicke M , et al.  European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood   Growth charts for prepubertal children with chronic renal failure due to congenital renal disorders . Pediatr Nephrol . 1996;10:288–293
  5. Schaefer F , Seidel C , Binding A , et al.   Pubertal growth in chronic renal failure . Pediatr Res . 1990;28:5–10
  6. Mehls O , Ritz E , Hunziker EB , et al.   Role of growth hormone in growth failure of uraemia—perspectives for application of recombinant growth hormone . Acta Paediatr Scand . 1988;343(suppl):118–126
  7. Wong CS , Gipson DS , Gillen DL , et al.   Anthropometric measures and risk of death in children with end-stage renal disease . Am J Kidney Dis . 2000;36:811–819
  8. Furth SL , Hwang W , Yang C , et al.   Growth failure, risk of hospitalization and death for children with end-stage renal disease . Pediatr Nephrol . 2002;17:450–455
  9. Furth SL , Stablein D , Fine RN , et al.   Adverse clinical outcomes associated with short stature at dialysis initiation (A report of the North American Pediatric Renal Transplant Cooperative Study) . Pediatrics . 2002;109:909–913
  10. Salusky IB . Bone and mineral metabolism in childhood end-stage renal disease . Pediatr Clin North Am . 1995;42:1531–1550
  11. Abitbol CL , Zilleruelo G , Montane B , et al.   Growth of uremic infants on forced feeding regimens . Pediatr Nephrol . 1993;7:173–177
  12. Lopez H , Dusso AS , Rapp NS , et al.   Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol . Am J Physiol . 1990;259:F432–F437
  13. Goodman WG . Recent developments in the management of secondary hyperparathyroidism . Kidney Int . 2001;59:1187–1201
  14. Chesney RW , Moorthy AV , Eisman JA , et al.   Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy . N Engl J Med . 1978;298:238–242
  15. Kuizon BD , Goodman WG , Juppner H , et al.   Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD . Kidney Int . 1998;53:205–211
  16. Chantler C , Holliday MA . Growth in children with renal disease with particular reference to the effects of calorie malnutrition (A review) . Clin Nephrol . 1973;1:230–242
  17. Sedman A , Friedman A , Boineau F , et al.   Nutritional management of the child with mild to moderate chronic renal failure . J Pediatr . 1996;129(suppl):S13–S18
  18. Rizzoni G , Broyer M , Guest G , et al.   Growth retardation in children with chronic renal disease (Scope of the problem) . Am J Kidney Dis . 1986;7:256–261
  19. Kaskel F . Chronic renal disease (A growing problem) . Kidney Int . 2003;64:1141–1151
  20. Schaefer F , Mehis O . Endocrine and growth disturbances . In:  Barrat MT ,  Avner ED ,  Harmon WE editor. Pediatric Nephrology . (ed 4). Baltimore, MD: Lippincott Williams and Wilkins; 1999;p. 1197–1230
  21. Van Dyck M , Bilem N , Proesmans W . Conservative treatment for chronic renal failure from birth (A 3-year follow-up study) . Pediatr Nephrol . 1999;13:865–869
  22. Scharer K  Study Group on Pubertal Development in Chronic Renal Failure . Growth and development of children with chronic renal failure . Acta Paediatr Scand . 1990;366(suppl):90–92
  23. Roelfsema V , Clark RG . The growth hormone and insulin-like growth factor axis (Its manipulation for the benefit of growth disorders in renal failure) . J Am Soc Nephrol . 2001;12:1297–1306
  24. Chen EY , Liao YC , Smith DH , et al.   The human growth hormone locus (Nucleotide sequence, biology, and evolution) . Genomics . 1989;4:479–497
  25. Goodman HM , Tai LR , Ray J , et al.   Human growth hormone variant produces insulin-like and lipolytic responses in rat adipose tissue . Endocrinology . 1991;129:1779–1783
  26. Kojima M , Hosoda H , Date Y , et al.   Ghrelin is a growth-hormone-releasing acylated peptide from stomach . Nature . 1999;402:656–660
  27. Shimon I , Taylor JE , Dong JZ , et al.   Somatostatin receptor subtype specificity in human fetal pituitary cultures (Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation) . J Clin Invest . 1997;99:789–798
  28. Powell DR , Durham SK , Liu F , et al.   The insulin-like growth factor axis and growth in children with chronic renal failure (A report of the Southwest Pediatric Nephrology Study Group) . J Clin Endocrinol Metab . 1998;83:1654–1661
  29. Yakar S , Liu JL , Le Roith D . The growth hormone/insulin-like growth factor-I system (implications for organ growth and development) . Pediatr Nephrol . 2000;14:544–549
  30. Feld S , Hirschberg R . Growth hormone, the insulin-like growth factor system, and the kidney . Endocr Rev . 1996;17:423–480
  31. Rodger RS , Dewar JH , Turner SJ , et al.   Anterior pituitary dysfunction in patients with chronic renal failure treated by hemodialysis or continuous ambulatory peritoneal dialysis . Nephron . 1986;43:169–172
  32. Powell DR , Liu F , Baker BK , et al.   Effect of chronic renal failure and growth hormone therapy on the insulin-like growth factors and their binding proteins . Pediatr Nephrol . 2000;14:579–583
  33. Edmondson SR , Baker NL , Oh J , et al.   Growth hormone receptor abundance in tibial growth plates of uremic rats (GH/IGF-I treatment) . Kidney Int . 2000;58:62–70
  34. Schaefer F , Chen Y , Tsao T , et al.   Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia . J Clin Invest . 2001;108:467–475
  35. Ulinski T , Mohan S , Kiepe D , et al.  The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood  German Study Group for Growth Hormone Treatment in Chronic Renal Failure   Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure (Relationship to growth and glomerular filtration rate) . Pediatr Nephrol . 2000;14:589–597
  36. Green J , Maor G . Effect of metabolic acidosis on the growth hormone/IGF-I endocrine axis in skeletal growth centers . Kidney Int . 2000;57:2258–2267
  37. Mehls O , Ritz E . Skeletal growth in experimental uremia . Kidney Int . 1983;15(suppl):S53–S62
  38. Nakano M , Kainer G , Foreman JW , et al.   The effects of exogenous rat growth hormone therapy on growth of uremic rats fed an 8% protein diet . Pediatr Res . 1989;26:204–207
  39. Mehls O , Ritz E , Hunziker EB , et al.   Improvement of growth and food utilization by human recombinant growth hormone in uremia . Kidney Int . 1988;33:45–52
  40. Powell DR , Rosenfeld RG , Hintz RL . Effects of growth hormone therapy and malnutrition on the growth of rats with renal failure . Pediatr Nephrol . 1988;2:425–430
  41. Lippe B , Fine RN , Koch VH , et al.   Accelerated growth following treatment of children with chronic renal failure with recombinant human growth hormone (somatrem) (A preliminary report) . Acta Paediatr Scand . 1988;343(suppl):127–131
  42. Koch VH , Lippe BM , Nelson PA , et al.   Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure . J Pediatr . 1989;115:365–371
  43. Fine RN , Koch VH , Nelson PA , et al.   Recombinant human growth hormone (rhGH) treatment of children with renal insufficiency . Adv Nephrol Necker Hosp . 1990;19:187–207
  44. Tonshoff B , Mehls O , Schauer A , et al.   Improvement of uremic growth failure by recombinant human growth hormone . Kidney Int . 1989;27(suppl):S201–S204
  45. Wilson DP , Jelley D , Stratton R , et al.   Nephropathic cystinosis (Improved linear growth after treatment with recombinant human growth hormone) . J Pediatr . 1989;115:758–761
  46. Fine RN , Pyke-Grimm K , Nelson PA , et al.   Recombinant human growth hormone treatment of children with chronic renal failure (Long-term (1- to 3-year) outcome) . Pediatr Nephrol . 1991;5:477–481
  47. Fine RN , Kohaut EC , Brown D , et al.   Growth after recombinant human growth hormone treatment in children with chronic renal failure (Report of a multicenter randomized double-blind placebo-controlled study) . J Pediatr . 1994;124:374–382
  48. Hokken-Koelega AC , Stijnen T , de Muinck Keizer-Schrama SM , et al.   Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure . Lancet . 1991;338:585–590
  49. Wuhl E , Haffner D , Nissel R , et al.  German Study Group for Growth Hormone Treatment in Chronic Renal Failure   Short dialyzed children respond less to growth hormone than patients prior to dialysis . Pediatr Nephrol . 1996;10:294–298
  50. Haffner D , Schaefer F , Nissel R , et al.  German Study Group for Growth Hormone Treatment in Chronic Renal Failure   Effect of growth hormone treatment on the adult height of children with chronic renal failure . N Engl J Med . 2000;343:923–930
  51. Berard E , Crosnier H , Six-Beneton A , et al.  French Society of Pediatric Nephrology   Recombinant human growth hormone treatment of children on hemodialysis . Pediatr Nephrol . 1998;12:304–310
  52. Broyer M  Pharmacia & Upjohn Study Group . Results and side-effects of treating children with growth hormone after kidney transplantation—a preliminary report . Acta Paediatrica . 1996;417(suppl):76–79
  53. Tonshoff B , Haffner D , Mehls O , et al.  Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts   Efficacy and safety of growth hormone treatment in short children with renal allografts (Three year experience) . Kidney Int . 1993;44:199–207
  54. Johansson G, Sietnieks A, Janssens F, et al: Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: An interim report on five European studies. Acta Paediatr Scand 370:36–42 (suppl)
  55. Maxwell H , Rees L  British Association for Pediatric Nephrology . Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients . Arch Dis Child . 1998;79:481–487
  56. Van Dop C , Jabs KL , Donohoue PA , et al.   Accelerated growth rates in children treated with growth hormone after renal transplantation . J Pediatr . 1992;120:244–250
  57. Fine RN , Kohaut E , Brown D , et al.   Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone . Kidney Int . 1996;49:781–785
  58. Hokken-Koelega A , Mulder P , De Jong R , Lilien M , Donckerwolcke R , Groothof J . Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency . Pediatr Nephrol . 2000;14:701–706
  59. Darendeliler F , Hindmarsh PC , Preece MA , et al.   Growth hormone increases rate of pubertal maturation . Acta Endocrinol (Copenh) . 1990;122:414–416
  60. Hochberg Z , Leiberman E , Landau H , et al.   Age as a determinant of the impact of growth hormone therapy on predicted adult height . Clin Endocrinol (Oxf) . 1994;41:331–335
  61. Wuhl E , Haffner D , Tonshoff B , et al.  German Study Group for Growth Hormone Treatment in Chronic Renal Failure   Predictors of growth response to rhGH in short children before and after renal transplantation . Kidney Int . 1993;43(suppl):S76–S82
  62. Christiansen JS , Gammelgaard J , Orskov H , et al.   Kidney function and size in normal subjects before and during growth hormone administration for one week . Eur J Clin Invest . 1981;11:487–490
  63. Haffner D , Zacharewicz S , Mehls O , et al.   The acute effect of growth hormone on GFR is obliterated in chronic renal failure . Clin Nephrol . 1989;32:266–269
  64. Prasad V , Greig F , Bastian W , et al.   Slipped capital femoral epiphysis during treatment with recombinant growth hormone for isolated, partial growth hormone deficiency . J Pediatr . 1990;116:397–399
  65. Rappaport EB , Fife D . Slipped capital femoral epiphysis in growth hormone-deficient patients . Am J Dis Child . 1985;139:396–399
  66. Mehls O , Broyer M  The European/Australian Study Group . Growth response to recombinant human growth hormone in short prepubertal children with chronic renal failure with or without dialysis . Acta Paediatr . 1994;399(suppl):81–87
  67. Boechat MI , Winters WD , Hogg RJ , et al.   Avascular necrosis of the femoral head in children with chronic renal disease . Radiology . 2001;218:411–413
  68. Mehls O , Ritz E , Krempien B , et al.   Slipped epiphyses in renal osteodystrophy . Arch Dis Child . 1975;50:545–554
  69. Catterall A , Roberts GC , Wynne-Davies R . Association of Perthes’ disease with congenital anomalies of genitourinary tract and inguinal region . Lancet . 1971;1:996–997
  70. Mehls O , Ritz E , Oppermann HC , et al.   Femoral head necrosis in uremic children without steroid treatment or transplantation . J Pediatr . 1981;99:926–929
  71. Nixon JR , Douglas JF . Bilateral slipping of the upper femoral epiphysis in end-stage renal failure (A report of two cases) . J Bone Joint Surg Am . 1980;62-B:18–21
  72. Van Dyck M , Gyssels A , Proesmans W , et al.   Growth hormone treatment enhances bone mineralisation in children with chronic renal failure . Eur J Pediatr . 2001;160:359–363
  73. Lanes R , Gunczler P , Orta N , et al.   Changes in bone mineral density, growth velocity and renal function of prepubertal uremic children during growth hormone treatment . Horm Res . 1996;46:263–268
  74. van der Sluis IM , Boot AM , Nauta J , et al.   Bone density and body composition in chronic renal failure (Effects of growth hormone treatment) . Pediatr Nephrol . 2000;15:221–228
  75. Fine RN , Ho M , Tejani A , et al.   Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease . J Pediatr . 2003;142:539–545
  76. Fujisawa Y , Kida K . Effect of growth hormone (GH) therapy on parathyroid hormone metabolism in a girl with GH deficient short stature and chronic renal failure . J Pediatr Endocrinol Metab . 1996;9:555–558
  77. Sieniawska M , Panczyk-Tomaszewska M , Ziolkowska H . The influence of growth hormone treatment on bone metabolism in dialysis patients . Br J Clin Pract . 1996;85(suppl):61–63
  78. Kaufman DB . Growth hormone and renal osteodystrophy (a case report) . Pediatr Nephrol . 1998;12:157–159
  79. Hokken-Koelega AC , Stijnen T , De Jong MC , et al.   Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency . J Clin Endocrinol Metab . 1994;79:1185–1190
  80. Fine RN . Recombinant human growth hormone in children with chronic renal insufficiency—clinical update (1995) . Kidney Int . 1996;53(suppl):S115–118
  81. Guest G , Berard E , Crosnier H , et al.  French Society of Pediatric Nephrology   Effects of growth hormone in short children after renal transplantation . Pediatr Nephrol . 1998;12:437–446
  82. Malozowski S , Tanner LA , Wysowski D , et al.   Growth hormone, insulin-like growth factor I, and benign intracranial hypertension . N Engl J Med . 1993;329:665–666
  83. Chang D , Nagamoto G , Smith WE . Benign intracranial hypertension and chronic renal failure . Cleve Clin J Med . 1992;59:419–422
  84. Watanabe S , Tsunematsu Y , Fujimoto J , et al.   Leukaemia in patients treated with growth hormone . Lancet . 1988;1:1159–1160
  85. National Kidney Foundation . K/DOQI clinical practice guidelines for nutrition in chronic renal failure . Am J Kidney Dis . 2000;35(suppl):S1–S140
  86. Rees L , Ward G , Rigden SP . Growth over 10 years following a 1-year trial of growth hormone therapy . Pediatr Nephrol . 2000;14:309–314
  87. Fine RN , Yadin O , Moulton L , et al.   Five years experience with recombinant human growth hormone treatment of children with chronic renal failure . J Pediatr Endocrinol . 1994;7:1–12

PII: S1548-5595(04)00118-1

doi: 10.1053/j.ackd.2004.07.005

Advances in Chronic Kidney Disease
Volume 11, Issue 4 , Pages 377-386 , October 2004

Article Tools

* Image Usage & Resolution